퓨즈

비상장계속사업자

FUZ. Co., Ltd

허재남

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

퓨즈

Business Reg. No. 1058686914 · CEO 허재남

I.Investment Overview

Target퓨즈 (1058686914)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명퓨즈
영문명FUZ. Co., Ltd
대표자허재남
사업자등록번호1058686914
법인등록번호1101113364877
설립일2005.12.22
종업원수34명

V.Workforce

34

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW116.22021119.32022123.220231122024129.72025
영업이익100M KRW8.320217.120228.420237.6202410.42025
순이익100M KRW6.820215.720223.320234.220244.22025
Item20252024202320222021
자산총계308.1억원297.3억원292.9억원192.7억원142억원
부채총계184.3억원176.8억원175.7억원145.7억원100.7억원
자본총계123.8억원120.5억원117.2억원47억원41.3억원
매출액129.7억원112억원123.2억원119.3억원116.2억원
영업이익10.4억원7.6억원8.4억원7.1억원8.3억원
순이익4.2억원4.2억원3.3억원5.7억원6.8억원

VII.Financial Ratios

FY2025 basis

8.03%

영업이익률

3.24%

순이익률

1.37%

ROA

3.4%

ROE

148.87%

부채비율

40.18%

자기자본비율

VIII.R&D Activity

Fields 보건의료 > 의료정보/ 시스템

Keywords 치위생, 인공지능, 클라우드

YearProjectsPapersPatents
2024110
2023100
2022110

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

퓨즈 투심보고서 | Alpha Lenz